First-line chemotherapy with Vinorelbine, Gemcitabine, and Carboplatin in the treatment of brain metastases from non-small-cell lung cancer: A phase II study

Cancer Investigation

Volumn 20, Issue 3, 2002, Pages 293-302

  Bernardo, Giovanni ^a   Cuzzoni, Quinto ^a   Strada, Maria Rosa ^a   Bernardo, Antonio ^a   Brunetti, Giuseppe ^a   Jedrychowska, Ivona ^a   Pozzi, Umberto ^a   Palumbo, Raffaella ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOPLATIN; GEMCITABINE; NAVELBINE;

ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG PENETRATION; FEMALE; HAIR LOSS; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROTOXICITY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; RASH; SURVIVAL TIME; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0036252666     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120001173     Document Type: Article

References (51)

1. Frequency of brain metastasis in adenocarcinoma and large-cell carcinoma of the lung: Correlation with survival
2. Brain metastases in adenocarcinoma of the lung: Frequency, risk groups and prognosis
3. A randomized trial of surgery in the treatment of single metastases to the brain
4. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery?
5. The choice of treatment of single brain metastases should be based on extracranial tumor activity and age
6. Stereotactic radiosurgery: A review and comparison of methods
7. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis
8. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: A review
9. The pharmacology of brain tumor chemotherapy
10. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors
11. Brain tumors and the blood tumor barrier
12. Systemic chemotherapy of brain metastases from small cell lung cancer: A review
13. Chemotherapy-induced regression of brain metastases in breast carcinoma
14. Chemotherapy with high-dose cisplatin in brain metastasis of lung cancer
15. Cisplatin-fotemustine combination in inoperable non-small-cell lung cancer: Preliminary report of a French multicenter phase II trial
16. Combination chemotherapy with carboplatin and etoposide of brain metastases from cancer
17. Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small-cell lung cancer
18. Teniposide plus lomustine in the treatment of brain metastasis in lung cancer
19. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors
20. Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma
21. Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastases in non-small-cell lung carcinoma
22. A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis
23. Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer
24. Chemotherapy for brain metastases of lung cancer: A review
25. A phase II study of navelbine (vinorelbine) in the treatment of non-small-cell lung cancer
26. Japan Navelbine Lung Cancer Study Group: A phase II study of navelbine, a new derivative of vinca alkaloid, for previously untreated non-small-cell lung cancer
27. Randomized study of vinorelbine and cisplatin vs. vindesine and cisplatin and cisplatin vs. vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
28. Vinorelbine vs. vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A randomized trial
29. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study
30. Activity of gemcitabine in patients with non-small-cell lung cancer: A multicenter extended phase II study
31. The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer
32. Cisplatin and gemcitabine in non-small-cell lung cancer
33. Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer
34. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer
35. Gemcitabine and vinorelbine in advanced non-small cell lung cancer
36. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
37. Prospective evaluation of a simple formula based on renal function
38. Reporting results of cancer treatment
39. Nonparametric estimation from incomplete observations
40. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized trials
41. Cost-effectiveness of navelbine regimes
42. Cost-effectiveness of gemcitabine in stage IV non-small-cell lung cancer: An estimate using the population health model lung cancer module
43. A phase II study of gemcitabine and carboplatin in NSCLC
44. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC). A Hoosier Oncology Group study
45. Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: A multicenter phase II study
46. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide
47. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small-cell lung cancer: A preliminary report
48. A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small-cell lung cancer
49. First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer
50. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, non-small-cell lung carcinoma, or malignant melanoma